The facility, which more than doubled R&D lab space to facilitate process transfer and development, also includes dedicated and separate microbial fermentation development, protein purification, ...

MISSISSAUGA, Ontario, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix ®), a life sciences innovator, manufacturer, and ...

ABBOTT PARK, Ill., April 14, 2015 /PRNewswire/ -- Today, Abbott (NYSE: ABT) and Sekisui announce an agreement to offer coagulation testing solutions for laboratories worldwide. Coagulation tests ...

- Sekisui Diagnostics to expand point of care testing portfolio with the FastPack® IP System from Qualigen Inc. - Qualigen expands their commercial reach through relationship with Sekisui Diagnostics ...

LEXINGTON, Mass., March 13, 2018 /PRNewswire/ -- Today Sekisui Diagnostics announces the launch of the Silaris ™ Influenza A&B Test. The Silaris ™ test was developed by Mesa Biotech and utilizes an ...

Sekisui Diagnostics has significantly expanded its point of care (POC) diagnostics product line through a recent partnership agreement with Qualigen, Inc. Sekisui Diagnostics is now the exclusive ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corporation (Nasdaq: GENZ) today announced that it has entered into an asset purchase agreement under which Sekisui Chemical Co., Ltd. will acquire Genzyme’s ...

Sekisui Chemical will pay $183 million to the Japanese drug firm Eisai to buy its Eidia unit, a provider of clinical diagnostic reagents, clinical analyzers, and laboratory reagents used in the ...

It was biotech's version of "buy-one-get-one" for Genzyme business units on Thursday. Sekisui Chemical Co. Ltd., of Osaka and Tokyo, started the business day Thursday by buying one – Genzyme's ...